Brother Enterprises (SZ:002562)2022-12-07 08:36Group 1: Investor Relations Activities - The investor relations activity included a site visit with participation from various financial institutions such as Guosen Securities and Tianhong Asset Management [2] - The meeting took place in October 2015 at the company's securities investment department meeting room [2] Group 2: Vitamin Market Situation - The company has achieved full capacity operation for its "annual production of 5,000 tons of Vitamin B3" project [3] - The "annual production of 13,000 tons of Vitamin B3 and 20,000 tons of 3-cyanopyridine construction project" aims to address production scale limitations and enhance market competitiveness [3] - The sales promotion of pharmaceutical-grade Vitamin B1 is progressing smoothly, with a stable competitive landscape in the market [3] Group 3: Leather Chemicals Market Situation - The leather industry in China has been undergoing environmental upgrades and industry consolidation, with signs of industrial transfer in the upstream processes [3] - The company has launched higher value-added coating agent products in the leather additives sector, which is expected to improve overall profitability [3] - The qualification certificate for the chromium-containing waste comprehensive utilization project was obtained in the first half of the year, and market promotion efforts are actively underway [3] Group 4: Project Construction Progress - The company officially started the construction of projects in the second quarter of the year, including Vitamin B3, Vitamin B5, and cogeneration projects [3] - The cogeneration project is expected to complete construction and begin trial production in the third quarter of 2016, providing centralized heating for the Qishan Industrial Park [3] Group 5: Legal Matters - The company is actively advancing the arbitration situation with Zhonghua Chemical and has executed part of the equity transfer prepayment at the beginning of the year [4]